SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX) -- Ignore unavailable to you. Want to Upgrade?

To: kenhott who wrote (185)9/20/2007 10:19:42 PM
From: tom pope  Read Replies (2) | Respond to of 269
 
Interesting point. Use a 2 inch needle on me and it would come out the other side. Invalidates everything.



To: kenhott who wrote (185)10/19/2007 3:20:40 PM
From: Archie Meeties  Respond to of 269
 
"So what is the data for BMI <30 or <25, etc. vs. BMI > 30, etc. etc.? I ask this because management's argument is based a lot on the patient group being too fat. So seems like the first logical cut should be on BMI."

Identical BMI's can have different distributions of fat so a BMI cutoff wouldn't work. Some of these differences are gender based.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News